🇪🇺 INOTUZUMAB OZOGAMICIN in European Union

INOTUZUMAB OZOGAMICIN (INOTUZUMAB OZOGAMICIN) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/004119
  • Local brand name: Besponsa
  • Status: approved

INOTUZUMAB OZOGAMICIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is INOTUZUMAB OZOGAMICIN approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for INOTUZUMAB OZOGAMICIN in European Union?

Marketing authorisation holder not available in our data.